Anthony Marucci
Fundador en CELLDEX THERAPEUTICS, INC. .
Fortuna: 1 M $ al 30/04/2024
Origen de la red de primer grado Anthony Marucci.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.
42
| Private Company | Miscellaneous Commercial Services | 42 |
| Public Company | Medical/Nursing Services | 30 | |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA.
18
| Extinct | Medical Specialties | 18 |
| Public Company | Pharmaceuticals: Major | 14 | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Celldex Research Corp. engages in provision of biological research and development. The company is headquartered in Phillipsburg, NJ.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anthony Marucci a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Boston University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| CELGENE | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HealthCare Institute of New Jersey | Corporate Officer/Principal Director/Board Member Director/Board Member | ||
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
National Tay-Sachs & Allied Diseases Association
 National Tay-Sachs & Allied Diseases Association Miscellaneous Commercial ServicesCommercial Services National Tay-Sachs & Allied Diseases Association is a non-profit organization. The firm engages in the provision of funding, research, and support services for individual affected with Tay-Sachs, Canavan, Sandhoff, GM1 gangliosidosis, and related diseases. The company was founded in 1957 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | President Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Consultant / Advisor | |
| Sentigen Biosciences, Inc. | Corporate Officer/Principal Private Equity Investor | ||
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Fondazione Ospedale San Raffaele | Corporate Officer/Principal Corporate Officer/Principal | ||
GeneSpire Srl
 GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Director/Board Member Founder | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| R.W. Johnson Pharmaceutical Research Institute | Corporate Officer/Principal Corporate Officer/Principal | ||
| PHIO PHARMACEUTICALS CORP. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Università Vita-Salute San Raffaele | College/University | Corporate Officer/Principal Doctorate Degree | |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Founder Director/Board Member | |
RHEI Pharmaceuticals, Inc.
 RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Founder Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 43 |
| Italia | 5 |
| Reino Unido | 3 |
| Francia | 2 |
| Israel | 2 |
Sectorial
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 4 |
Operativa
| Director/Board Member | 456 |
| Corporate Officer/Principal | 241 |
| Independent Dir/Board Member | 130 |
| Chairman | 116 |
| Chief Executive Officer | 87 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Stephen P. Squinto | 40 |
| Una Ryan | 38 |
| Garry Neil | 38 |
| Sol Barer | 32 |
| Harry Penner | 31 |
| Timothy Shannon | 28 |
| James Sapirstein | 26 |
| Andrew Pecora | 25 |
| Geert Cauwenbergh | 22 |
| Daniel O'Connor | 22 |
| Herbert Conrad | 21 |
| Cheryl L. Cohen | 20 |
| Roger Abravanel | 19 |
| George Elston | 18 |
- Bolsa de valores
- Insiders
- Anthony Marucci
- Conexiones Empresas
